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Flow diverters (FDs) are being used with increasing frequency, especially to target large
and complex aneurysms not amenable to treatment with conventional endovascular
methods.8,10,11,26 The Pipeline embolization device (PED) is the first FD approved by
the FDA following the results of the PUFS trial for the management of large or giant
wide-necked intracranial aneurysms in the internal carotid artery from the petrous to
the superior hypophyseal segments. Although initially indicated for a limited type of
aneurysms, the use of the PED is being extended for the management of a variety of
aneurysms in different settings.5-7,9 The main factors that are considered in deciding if an
aneurysm is suitable for treatment with the PED include aneurysm size, location, geometry and shape and rupture status.16 Studies have shown a high technical success rate,
a high rate of aneurysm occlusion accompanied by low recurrence and re-treatment
rates.10,12,20 Current evidence also supports the PED as a safe device associated with
low morbidity and mortality.10,21,23,27 Although treatment failure with flow diversion has
been reported, the characteristics of these aneurysms with persistent filling have not
been well established. Furthermore, the course of these aneurysms remains a topic of
uncertainty. The initial thrombosis caused by FDs does not result in immediate cure of
the aneurysm rather FDs act as a scaffold for endothelial overgrowth at the aneurysm
neck resulting intra-aneurysmal flow stasis and thrombosis while promoting remodeling
of the parent vessel and parent vessel reconstruction which results in gradual occlusion
of the aneurysm.22
Prior literature on the efficacy of PED have shown a high complete aneurysm occlusion rate, with most studies reporting occlusion rates > 80% 3,13 and this compares
favorably to endovascular coil embolization, where the reported complete occlusion
rate is 66%( ISAT).4 Recurrence after successful PED treatment has not been reported
with the available short- and medium-term data. This is in contrast to high recurrence
rates with coiling (9-34% at 12 months) that increases with large, giant, wide-necked,
and nonsaccular aneurysms that are the target for PED treatment.1 The retreatment
rate is much lower with PED treatment as compared to coiling in ISAT (17.4%).4 Flow
diverters seem to be more effective than the conventional endovascular techniques
in select cases.
Aneurysm location in the distal anterior circulation (PCOM artery, anterior choroidal
artery and MCA) is a significant predictor of persistent aneurysm. Parent vessels
for such aneurysms are usually small, and aneurysms often arise at major branch
points. In addition, the A1 segment of the ACA and M1 segment of the MCA are rich in
lenticulo-striate perforators, and covering these areas with PEDs could theoretically
increase the risk of perforator strokes with neurological deficits. These factors render
PED delivery and deployment more difficult. Also, PEDs (with available sizes from 2.5
to 5 mm) are in general designed for parent vessels that are larger than the caliber
of distal anterior circulation vessels. In a small vessel, the device may be elongated
and the stent pores may become larger which may impair the flow diversion effect
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and lower the chances of aneurysm
thrombosis. This may affect the reliability
of PED deployment in smaller distal
vessels. However, there are some distal
anterior circulation aneurysms that are
morphologically challenging for either
traditional microsurgical or endovascular approaches, and the use of PEDs
may have an advantage in these cases.
In these cases, placing a single, long flow
diverter stent and avoiding telescoping
of multiple devices along perforator-rich
segments can reduce the risk of perforator occlusion.
The PED was originally approved for the
treatment of aneurysms proximal to the
PCOM artery.14 PCOMA aneurysms are
among the most frequently encountered
cerebral aneurysms. A fetal PCOM artery
is an end vessel with no distal collaterals.
Since fetal PCOM arteries represent the
only supply to the PCA, care should be
taken when treating PCOM aneurysms
incorporating a fetal variant.19 In fact, fetal
PCOM artery aneurysms are often treated
surgically since endovascular therapy is
thought to cause a higher treatment risk.19
Several reports have suggested that flow
diversion for fetal PCOM aneurysms is
ineffective and does not lead to aneurysm occlusion and has high potential
for serious complications.17,19 Aneurysms
arising from a fetal PCOM are less likely
to be occluded even after placement of
a flow diverter due to the high flow and
the high physiological demand for this
artery which maintains pressure gradient
across the ostium.14 PCOM aneurysms
with a fetal PCA are better to be treated
with microsurgical clipping.18 Attempting
flow diversion may add procedural risks
and make surgical clipping even more
technically complex.
MCA aneurysms represent the third most
common cause of subarachnoid hemorrhage and almost 1/5 of unruptured
aneurysms. 24 The majority of MCA aneurysms arise at the level of the bifurcation
tend to be wide-necked, incorporate one
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or more side branch vessels and tend to
have an unfavorable anatomical configuration.15 Wide-necked MCA bifurcation
lesions have been classically treated
with microsurgery with excellent results.
Traditional endovascular approaches can
sometimes be challenging with a risk of
occluding branch vessels as well as the
risk of coil herniation. Flow diversion for
MCA aneurysms should be considered
when other surgical or endovascular
approaches are not an option or do not
offer superior outcomes and for lesions
that persist after previous surgery or
endovascular treatment. 26 Clinical data
should demonstrate better or similar
results than clipping to challenge surgical
intervention, with current occlusion rates
from clipping reported to be >90% in
most studies. 25
Stent placement negatively affects the
safety and efficacy of the PED in the
management of recurrent aneurysms.
The rate of complete aneurysm occlusion
is lower in previously stented aneurysms
(50-65%) with potential for a higher
complication rate (14.3%) and technical failure rate. 28 If a stent was placed
initially, recurrence would be less eligible
for PED treatment and might require
surgical clipping to achieve aneurysm
occlusion. The presence of a previous
stent may: reduce the hemodynamic
effect of the PED, disrupt the process of
wall apposition of the PED to the parent
vessel, preventing the endothelialization
process inhibiting complete aneurysm
occlusion, complicate the navigation of
the delivery catheter into position and
the actual deployment of the PED and
because the PED should be deployed
distal to the stent, the distal end of the
PED may “catch” on the previously placed
stent, which may cause anchoring and
stretching of the device, leading to less
effective results. It is important to note
that patients of advanced age can have a
weaker neo-intimal response and therefore may have higher odds of incomplete
aneurysm occlusion.
The majority of cases require the placement of only one PED, and a single PED
should be usually placed as there was no
difference in aneurysm occlusion when
more than 1 device were deployed. 29
Coiling and flow diversion have been
shown to be complementary, rather than
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competitive modalities for intracranial
aneurysm treatment. 3 Using coils along
with the PED in select cases can be more
effective with a higher occlusion rate and
lower retreatment rate, by promoting
endosaccular thrombosis and providing
a mechanical scaffold.
The PED is indicated for large and giant
aneurysms.4 However, large and giant
aneurysms represent a small fraction of
all cerebral aneurysms with the majority
of aneurysms in the general population
being <10 mm in size. Traditional endovascular strategies including coiling and
stent-assisted coiling are usually used
for small aneurysms (≤ 7 mm). Some
retrospective studies have demonstrated
high occlusion rates (75-90%) and low
complication rates (<5%) with treating
these small aneurysms.10 In experienced
centers the PED is demonstrating a
better efficacy profile and a similar safety
profile to coiling of smaller aneurysms.10
With the increasing use of the PED for the
treatment of small, simple aneurysms,
the question arises as to whether the use
of this device routinely, or even as a first
line treatment for these aneurysms is as
safe and effective as the current standard
endovascular techniques. This needs to
be further studied
Good clinical outcomes have been
reported with flow diversion of saccular
or non-symptomatic fusiform posterior
circulation aneurysms. 3 Treatment with
the PED may be a preferable alternative
to open surgical treatment for these
aneurysms. Because of the large number
of perforating vessels in the posterior
circulation that supply vital brainstem
structures, complex aneurysm anatomy,
and aneurysm location, flow diversion
should be used with caution. Aneurysm
morphology and presentation are critical
factors to consider when selecting
posterior circulation aneurysms for
treatment with the PED.30
Device deployment is successful in 95%
to 100% of cases (99% in PUFS).2 Selection of the appropriate diameter and
length of the device is essential to ensure
proper device function and to minimize
the chance for unanticipated stent
shortening or migration. (FDA-Summary
of Safety and Effectiveness of Data,
PED, P100018) The delivery catheter

must recross the PED over the delivery
wire to recapture the distal coil tip after
complete stent deployment. Up to 50%
foreshortening is expected when fully
deployed compared with 1.5% -7.1% and
1.8%-5.4% foreshortening in Wingspan®
and Neuroform® 3 stents. (Bench testing
conducted by Boston Scientific)
There is a potential risk of an endoleaklike phenomenon with implantation of an
undersized device, which results in poor
wall apposition. Similarly, implantation of
an oversized device may result in poor
coverage of the lesion because of an
incomplete compaction of the strands. 31
When a branch vessel is incorporated
into the target aneurysm, its runoff
can potentially contribute to persistent
filling of the aneurysm by the very same
physiological processes theoretically
responsible for the preservation of jailed
branch vessels and perforators arising
from normal segments. One may expect
that final closure of such aneurysms
would require concomitant occlusion of
the associated branch.
While the PED can allow for treatment of
large, wide-necked aneurysms with high
efficacy, aneurysm location, previous
treatment, patient age and the use of
concomitant coiling may influence treatment outcomes.
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